Erythrocyte phosphoglucomutase activity of bipolar I patients currently using lithium or carbamazepine

Brazilian Journal of Medical and Biological Research

Volumn 40, Issue 1, 2007, Pages 19-25

  Montero Lomeli M ^a   Galvao G ^a   Morais, B B ^a   Nardi, A E ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Bipolar disorder; Carbamazepine; Lithium; Phosphoglucomutase

Indexed keywords

CARBAMAZEPINE; CHLORPROMAZINE; DIAZEPAM; GLYCOGEN; HALOPERIDOL; HEMOGLOBIN; IMIPRAMINE; LITHIUM; OLANZAPINE; PHOSPHOGLUCOMUTASE; PROMETHAZINE; VALPROIC ACID;

ADULT; ARTICLE; BIPOLAR I DISORDER; BLOOD SAMPLING; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG TARGETING; DRUG UTILIZATION; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; GLYCOGEN METABOLISM; HUMAN; IC 50; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY;

ORYCTOLAGUS CUNICULUS;

EID: 33846271107     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2007000100003     Document Type: Article

References (17)

1. Coryell W, Solomon D, Leon AC, Akiskal HS, Keller MB, Scheftner WA, et al. Lithium discontinuation and subsequent effectiveness. Am J Psychiatry 1998; 155: 895-898.
2. Klein PS, Melton DA. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci U S A 1996; 93: 8455-8459.
3. Kao KR, Elinson RP. The legacy of lithium effects on development. Biol Cell 1998; 90: 585-589.
4. Peters DJ, van Lookeren Campagne MM, Van Haastert PJ, Spek W, Schaap P. Lithium ions induce prestalk-associated gene expression and inhibit prespore gene expression in Dicityostelium discoideum. J Cell Sci 1989; 93 (Pt 1): 205-210.
5. Stambolic V, Ruel L, Woodgett JR. Lithium inhibits glycogen synthese kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol 1996; 6: 1664-1668.
6. Hedgepeth CM, Conrad LJ, Zhang J, Huang HC, Lee VM, Klein PS. Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Dev Biol 1997; 185: 82-91.
7. York JD, Ponder JW, Majerus PW. Definition of a metal-dependent/ Li(+)-inhibited phosphomonoesterase protein family based upon a conserved three-dimensional core structure. Proc Natl Acad Sci U S A 1995; 92: 5149-5153.
8. Masuda CA, Xavier MA, Mattos KA, Galina A, Montero-Lomeli M. Phosphoglucomutase is an in vivo lithium target in yeast. J Biol Chem 2001; 276: 37794-37801.
9. Nordenberg J, Kaplansky M, Beery E, Klein S, Beitner R. Effects of lithium on the activities of phosphofructokinase and phosphoglucomutase and on glucose-1,6-diphosphate levels in rat muscles, brain and liver. Biochem Pharmacol 1982; 31: 1025-1031.
10. Bro C, Regenberg B, Lagniel G, Labarre J, Montero-Lomeli M, Nielsen J. Transcriptional, proteomic, and metabolic responses to lithium in galactose-grown yeast cells. J Biol Chem 2003; 278: 32141-32149.
11. Csutora P, Karsai A, Nagy T, Vas B, Kovacs L, Rideg O, et al. Lithium induces phosphoglucomutase activity in various tissues of rats and in bipolar patients. Int J Neuropsychopharmacol 2005; 1-7.
12. American Psychiatric Association. Diagnostic and statistical manual for mental disorders - DSM-IV. 4th edn. Washington: American Psychiatric Press; 1994.
13. First MB, Spitzer RL, Gibbon M, Williams JBM. Structured clinical. interview diagnostic (SCID) for DSM-IV axis I disorders-clinician version (SCID-CV). Washington: American Psychiatric Press; 1997.
14. Bergmeyer HU. Methods in enzymatic analysis. 3rd edn. Weinheim: Verlag Chemie; 1986.
15. Drabkin DL. The molecular weight of haemoglobin, its iron and nitrogen content and optical properties - their relevance in the problem of a reference standard for haemoglobin measurement. Bibl Haematol 1965; 21: 33-42.
16. Brown AM, Baltan TS, Ransom BR. Energy transfer from astrocytes to axons: the role of CNS glycogen. Neurochem Int 2004; 45: 529-536.
17. Bowley MP, Drevets WC, Ongur D, Price JL. Low glial numbers in the amygdala in major depressive disorder. Biol Psychiatry 2002; 52: 404-412.